Journal
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Volume 4, Issue 12, Pages 2040-2044Publisher
AMER SOC NEPHROLOGY
DOI: 10.2215/CJN.04210609
Keywords
-
Categories
Funding
- Astellas Canada
- Roche Canada
- Novartis Canada
- Wyeth Canada
- Genzyme Canada
Ask authors/readers for more resources
For the average patient with ESRD, kidney transplantation improves quality of life and prolongs survival compared with patients who are on the transplant waiting list and remain on dialysis. Despite the proven benefits, some patient populations, such as those of older age, may not be referred and accepted for kidney transplantation to the same extent as younger patients. The population with ESRD is aging. Nearly half of all new patients are older than 65 yr. Nephrologists and transplant surgeons will need to make more and more decisions regarding transplantation referral and candidacy in this population. This article reviews the data on survival, quality of life, and cost-effectiveness of kidney transplantation in the older dialysis patient. Clinical guidelines and data on current practice are also reviewed. Clin J Am Soc Nephrol 4: 2040-2044, 2009. doi: 10 2215/CJN.04210609
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available